Macquarie Group
VTYX

Macquarie Group’s Ventyx Biosciences VTYX Stock Holding History

Macquarie Group’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-430,000
Closed -$1.34M – 1494
2025
Q3 		$1.34M Hold
430,000
– – ﹤0.01% 1273
2025
Q2 		$920K Hold
430,000
– – ﹤0.01% 1384
2025
Q1 		$495K Hold
430,000
– – ﹤0.01% 1477
2024
Q4 		$942K Hold
430,000
– – ﹤0.01% 1363
2024
Q3 		$937K Hold
430,000
– – ﹤0.01% 1391
2024
Q2 		$993K Hold
430,000
– – ﹤0.01% 1383
2024
Q1 		$2.37M Buy
+430,000
New +$1.97M ﹤0.01% 1174
2023
Q4 		– Sell
-22,520
Closed -$782K – 1688
2023
Q3 		$782K Buy
22,520
+439
+2% +$15.2K ﹤0.01% 1390
2023
Q2 		$724K Buy
+22,081
New +$761K ﹤0.01% 1409

Other funds holding VTYX

AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Macquarie Group's VTYX Position: Q4 2025 in Review

Macquarie Group sold out of Ventyx Biosciences (VTYX) in Q4 2025, closing a stake of 430,000 shares — an estimated $1.34M sold.

Macquarie Group first reported a position in VTYX in Q2 2023 and held it in 9 quarters. The position peaked at $2.37M in Q1 2024. 139 funds tracked by Wall St. Rank hold VTYX as of Q4 2025.

  • Macquarie Group reported no remaining Ventyx Biosciences position as of Q4 2025 after selling out during the quarter.
  • Macquarie Group sold 430,000 Ventyx Biosciences shares in Q4 2025, an estimated $1.34M.
  • Macquarie Group first reported a position in Ventyx Biosciences in Q2 2023 and held it in 9 quarters.
  • Macquarie Group's Ventyx Biosciences position peaked at $2.37M in Q1 2024.
  • 139 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.